Aveeno

Aveeno is an American skincare and hair-care brand whose identity is closely associated with colloidal oatmeal and oat-derived ingredients. Its products are positioned around gentle care for dry, sensitive, irritated, and condition-prone skin, with ranges spanning facial care, body moisturizers, cleansers, bath products, sun care, hair care, and baby care. The brand name is derived from Avena sativa, the scientific name for the common oat. The brand was established in 1945 by brothers Albert and Sidney Musher in collaboration with the Mayo Clinic. Their early work focused on finely milled colloidal oatmeal and its potential to soothe dry and sensitive skin. Aveeno's first product was Soothing Bath Treatment, an oatmeal-based bath preparation that established the ingredient platform later used throughout the portfolio. In 1961, the business adopted the name Aveeno Pharmaceuticals, with Albert Musher as president and Sidney Musher as vice president. Aveeno subsequently passed through several corporate owners. Cooper Laboratories acquired the brand and operated it through its Coopercare division. S.C. Johnson & Son purchased Aveeno from Cooper Laboratories in 1984, and the brand remained associated with the company's Rydelle Laboratories division until that division's name was discontinued in 1989. Johnson & Johnson acquired the company's skincare business, including Aveeno, in 1999. Under Johnson & Johnson, the packaging was redesigned and Aveeno was repositioned as a premium, naturally oriented skincare brand while retaining its mass-market distribution. During the 2000s, Aveeno broadened beyond its original bath-treatment heritage. The portfolio added soy-based products, stress-relief products, Aveeno Baby, and Skin Relief Body Wash in 2001. Positively Radiant entered facial care in 2004, followed by Clear Complexion acne care in 2005, Ultra-Calming in 2006, and Anti-Aging in 2007. These launches extended the brand into concerns including uneven tone, acne, redness, and visible signs of aging while maintaining its emphasis on ingredient-led, relatively gentle formulations. Aveeno also developed a strong association with dermatological and sensitive-skin use cases. Its products have been marketed for or used in connection with concerns such as eczema, psoriasis, urushiol-induced contact dermatitis, itching, chickenpox-related irritation, hives, and sunburn. The brand describes avenanthramides, compounds found in oats, as part of its "Active Naturals" ingredient platform. Its best-known consumer proposition combines science-informed formulation with a natural ingredient story rather than presenting the brand as a purely botanical or medicinal line. By 2014, Aveeno's US body-care products were reported to have exceeded $100 million in sales and to rank third in market share in their segment, although this historical financial information is not reproduced here without a dedicated financial source. The brand entered China through Tmall in 2016, extending its international footprint through an e-commerce-led route to market. In 2023, Aveeno moved from Johnson & Johnson to Kenvue when Johnson & Johnson separated its consumer-health business into an independent company. Reference material also reports that Kimberly-Clark acquired Kenvue in 2025. Aveeno therefore remains an active consumer skincare brand within the Kenvue portfolio, subject to the ownership structure described in the cited reference material. Its current brand promise continues to center on oat-based care, sensitive-skin expertise, broad household accessibility, and products for adults, children, and babies.

Aveeno originated in 1945 when brothers Albert and Sidney Musher worked with the Mayo Clinic on the use of finely milled colloidal oatmeal for dry and sensitive skin. Their first commercial product, Soothing Bath Treatment, established the core ingredient and therapeutic-care orientation that still characterize the brand. The name Aveeno comes from Avena sativa, the botanical name of the common oat. In 1961, the company changed its name to Aveeno Pharmaceuticals. Albert Musher served as president and Sidney Musher as vice president. The brand later became part of Cooper Laboratories, where it was placed within the Coopercare division. S.C. Johnson & Son acquired Aveeno from Cooper Laboratories in 1984. It was subsequently associated with S.C. Johnson's Rydelle Laboratories division, whose name was discontinued in 1989. Johnson & Johnson purchased the relevant skincare business, including Aveeno, in 1999. The new owner redesigned the packaging and repositioned the brand as a higher-end natural skincare offering. This period marked a transition from a focused oatmeal bath-treatment business to a broader consumer skincare platform. Aveeno expanded into baby care, stress-relief products, soy-based formulations, body wash, facial care, acne care, calming products, and anti-aging products during the 2000s. The brand's major 2000s extensions included Aveeno Baby and Skin Relief Body Wash in 2001; Positively Radiant facial care in 2004; Clear Complexion acne care in 2005; Ultra-Calming in 2006; and Anti-Aging in 2007. These lines allowed Aveeno to address multiple consumer concerns while preserving its association with mildness and oat-derived ingredients. Aveeno products have also been marketed for conditions and symptoms including eczema, psoriasis, contact dermatitis caused by urushiol, itching, chickenpox irritation, hives, and sunburn. Aveeno's marketing increasingly connected scientific formulation with natural ingredients. The brand identifies colloidal oats, oat extracts, and avenanthramides as central to its Active Naturals platform. It has operated across facial, body, baby, hair, bath, and sun-care categories. In 2013, Jennifer Aniston became a brand spokesperson after Daniella van Graas. In 2014, reference material reported that Aveeno's US body-care business had exceeded $100 million and held third place by market share in its segment. The brand entered China through Tmall in 2016. Aveeno became part of Kenvue in 2023 when Johnson & Johnson separated its consumer-health operations into a new company. Reference material further reports a 2025 acquisition of Kenvue by Kimberly-Clark. A further reference reports that Aveeno announced a three-year research and innovation collaboration with the Mayo Clinic in 2026, intended to advance knowledge of skin health and product development. Because the latter event is dated beyond the currently established historical record in many general references, it should be independently verified before being treated as a completed historical milestone.

1. 2026Reported Mayo Clinic research collaboration

   Reference material reports a three-year Aveeno and Mayo Clinic research and innovation collaboration focused on skin health and product development.

   Source
2. 2025Reported Kenvue acquisition by Kimberly-Clark

   Reference material reports that Kimberly-Clark acquired Kenvue, placing Aveeno within a new corporate ownership context.

   Source
3. 2023Aveeno becomes part of Kenvue

   Aveeno moves into Kenvue following Johnson & Johnson's separation of its consumer-health operations.

   Source
4. 2016Aveeno enters China through Tmall

   The brand establishes a Chinese-market presence through the Tmall e-commerce platform.

   Source
5. 2007Anti-Aging line launches

   Aveeno enters the anti-aging skincare segment.

   Source
6. 2006Ultra-Calming launches

   Aveeno adds a facial-care line aimed at calming sensitive or visibly irritated skin.

   Source
7. 2005Clear Complexion launches

   The brand introduces a facial acne-care range.

   Source
8. 2004Positively Radiant launches

   Aveeno enters facial care with the Positively Radiant line, centered on Active Soy.

   Source
9. 2001Portfolio expands into baby and skin-relief care

   Aveeno adds soy and stress-relief products, Aveeno Baby, and Skin Relief Body Wash.

   Source
10. 1999Johnson & Johnson acquires Aveeno's skincare business

    Johnson & Johnson acquires the skincare business containing Aveeno and begins a packaging and positioning refresh.

    Source
11. 1984S.C. Johnson & Son acquires Aveeno

    S.C. Johnson & Son purchases the brand from Cooper Laboratories.

    Source
12. 1961Company adopts the Aveeno Pharmaceuticals name

    The business changes its name to Aveeno Pharmaceuticals, with Albert Musher as president and Sidney Musher as vice president.

    Source
13. 1945Aveeno is founded

    Albert and Sidney Musher establish Aveeno in collaboration with the Mayo Clinic and introduce an oatmeal-based soothing bath treatment.

    Source

A mass-to-premium accessible skincare brand emphasizing oat-based ingredients, sensitive-skin suitability, dermatological credibility, and gentle everyday care.

• Soothing Bath TreatmentBath and skin-relief treatment1945

  Aveeno's first product, introduced from the brand's early work with the Mayo Clinic. It uses finely milled colloidal oatmeal in a bath-treatment format intended to soothe dry and irritated skin.

• Daily MoisturizingBody moisturization

  A core everyday-moisturization platform associated with Aveeno's oat-based body-care positioning. Products in this family are designed for routine care of dry skin and help anchor the brand's broad household distribution.

• Positively RadiantFacial skincare2004

  A facial-care line launched in 2004 and built around Aveeno's Active Soy ingredient platform. It broadened the brand into products addressing the appearance of uneven tone and radiance.

• Clear ComplexionAcne care2005

  An acne-care range introduced in 2005. It extended Aveeno's facial portfolio from general moisturization and radiance into blemish-oriented skincare.

• Ultra-CalmingSensitive-skin facial care2006

  A facial-care platform launched in 2006 for consumers seeking products associated with calming visibly sensitive or irritated skin. It reinforces Aveeno's sensitive-skin specialization.

• Aveeno BabyBaby skincare2001

  A baby-care portfolio introduced during Aveeno's early-2000s expansion. It applies the brand's gentle, oat-centered positioning to cleansing, moisturizing, and routine care for babies.

• Skin ReliefBody care and skin relief2001

  A body-care platform associated with dry, itchy, and sensitive-skin needs. The range includes body washes and moisturizers and reflects Aveeno's connection with dermatological skin-relief use cases.

• 2013Jennifer Aniston spokesperson campaign

  United States · International markets

  Aveeno appointed Jennifer Aniston as a spokesperson, using a high-profile celebrity partnership to support the brand's accessible premium skincare and natural-ingredient positioning.

  Outcome. Aniston replaced long-serving spokesperson Daniella van Graas; longer-term campaign performance is not specified in the available reference.

  Source

• 2026Reported Mayo Clinic research collaborationStrategy

  Reference material describes a planned effort to deepen research into skin health and product innovation.

  What changed. Aveeno reportedly announced a three-year research and innovation collaboration with the Mayo Clinic.

  Aftermath. The collaboration's results are not specified. The reported event requires independent verification.

  Source
• 2023Transfer to KenvueM&A

  Johnson & Johnson separated its consumer-health operations into Kenvue.

  What changed. Aveeno became part of Kenvue's consumer-health and personal-care portfolio.

  Aftermath. Aveeno continued as an active standalone brand under the new corporate structure.

  Source
• 2004Entry into facial skincareProduct launch

  Aveeno sought to extend its oatmeal-centered body and bath-care heritage into facial skincare.

  What changed. The brand launched Positively Radiant, based on its Active Soy ingredient platform.

  Aftermath. The launch established facial care as a significant part of the brand's category architecture.

  Source
• 1999Johnson & Johnson acquires the brandM&A

  Aveeno's skincare business was acquired as part of Johnson & Johnson's expansion of its consumer-health and skincare portfolio.

  What changed. Johnson & Johnson acquired the business and subsequently redesigned Aveeno packaging and repositioned the brand as a higher-end natural skincare offering.

  Aftermath. The move preceded a broad expansion into facial, baby, acne, calming, and anti-aging categories.

  Source

• 2023Legal action following sunscreen recallControversy

  Legal action connected with the aerosol sunscreen contamination and recall was reported as settled in 2023.

  Source
• 2021Aerosol sunscreen benzene recallControversy

  Several Aveeno and Neutrogena aerosol sunscreens were recalled in the United States after benzene was detected. Johnson & Johnson stated that benzene was not used as an intended manufacturing ingredient and said it was investigating the contamination source.

  Source
• Criticism over microbeadsControversy

  Aveeno was criticized for selling products containing microbeads, plastic particles that may pass through wastewater systems and reach aquatic environments. Johnson & Johnson stated that it would remove microbeads from its products by 2017.

  Source

• 2025Kenvue reportedly acquired by Kimberly-Clark

  Reference material reports that Kimberly-Clark acquired Kenvue, changing the wider corporate ownership context for Aveeno.

  M&A
  Source
• 2023Aveeno transfers to Kenvue after Johnson & Johnson consumer-health separation

  Aveeno became part of Kenvue when Johnson & Johnson separated its consumer-health businesses into a standalone company.

  M&A
  Source
• 2016Aveeno expands into China through Tmall

  Aveeno entered the Chinese market through the Tmall e-commerce platform.

  Other
  Source
• 2013Jennifer Aniston becomes Aveeno spokesperson

  Jennifer Aniston was announced as an Aveeno spokesperson, replacing Daniella van Graas, who had represented the brand for many years.

  CampaignLeadership change
  Source
• 2004Aveeno adds new facial-care range with Positively Radiant

  Aveeno entered facial care with Positively Radiant, a line built around the brand's Active Soy ingredient platform.

  Product launchProduct generation
  Source

1. Aveeno
2. Aveeno official website